2 studies tanks CRSP and EDIT. What now?

Cas9 might cause cancer

news dropped the stock by 12% already. Once again proving growth pharma stocks are scary water to tread.

Submitted June 11, 2018 at 12:20PM by Signedupforgonewild https://ift.tt/2Jzhj6t